546 — Medtecs International Cashflow Statement
0.000.00%
- SG$74.11m
- SG$67.35m
- $52.64m
- 61
- 50
- 52
- 56
Annual cashflow statement for Medtecs International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.52 | 135 | 16.9 | -30.7 | -22.5 |
Depreciation | |||||
Non-Cash Items | 2.52 | 1.75 | 2.86 | 15.3 | 9.55 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.47 | -43.2 | 3.8 | 10.4 | -1.32 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.37 | 102 | 30.1 | 1.26 | -7.18 |
Capital Expenditures | -4.57 | -8.4 | -16.4 | -15.3 | -7.41 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.077 | 2.22 | 0.985 | -13.9 | 17 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -4.65 | -6.18 | -15.4 | -29.2 | 9.61 |
Financing Cash Flow Items | -2.68 | -1.43 | 1.64 | -0.375 | -5.29 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.17 | -16.3 | -47.5 | -3.02 | 1.84 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.45 | 79.1 | -33.1 | -30.9 | 4.18 |